ALTIMMUNE, INC. Financing Cash Flow
ALTIMMUNE, INC. (ALT) reported Financing Cash Flow of $289.54 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-12
- ALTIMMUNE, INC. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was $211.07M, a 304.01% increase year-over-year.
- ALTIMMUNE, INC. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was $78.47M, a 130.00% increase year-over-year.
- ALTIMMUNE, INC. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $81.13M, a 704.46% increase year-over-year.
- ALTIMMUNE, INC. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $39.35M, a 14692.86% increase year-over-year.
- ALTIMMUNE, INC. net cash provided by (used in) financing activities for fiscal 2025 was $206.84M, a 1959.36% increase from fiscal 2024.
- ALTIMMUNE, INC. net cash provided by (used in) financing activities for fiscal 2024 was $10.04M, a 88.34% decline from fiscal 2023.
- ALTIMMUNE, INC. net cash provided by (used in) financing activities for fiscal 2023 was $86.11M, a 51.64% increase from fiscal 2022.
- ALTIMMUNE, INC. net cash provided by (used in) financing activities for fiscal 2022 was $56.78M, a 12.78% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 3 month as first filed | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 6 month as first filed | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 9 month as first filed | Net Cash Provided by (Used in) Financing Activities 12 month | Net Cash Provided by (Used in) Financing Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $211.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $289.54M 10-Q · filed 2026-08-12 | $370.67M derived: sum of 3 quarters · filed 2026-08-12 | $410.02M derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2026-03-31 | $78.47M 10-Q · filed 2026-05-13 | $159.60M derived: sum of 2 quarters · filed 2026-05-13 | $198.95M derived: sum of 3 quarters · filed 2026-05-13 | $251.20M derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2025-12-31 | $81.13M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06 | $120.48M derived: sum of 2 quarters · filed 2026-03-06 | $172.72M derived: sum of 3 quarters · filed 2026-08-12 | $206.84M 10-K · filed 2026-03-06 | ||||
| 2025-09-30 | $39.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $91.59M derived: sum of 2 quarters · filed 2026-08-12 | $125.71M 10-Q · filed 2025-11-06 | $135.80M derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2025-06-30 | $52.24M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $86.36M 10-Q · filed 2026-08-12 | $96.45M derived: sum of 3 quarters · filed 2026-08-12 | $96.71M derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2025-03-31 | $34.12M 10-Q · filed 2026-05-13 | $44.20M derived: sum of 2 quarters · filed 2026-05-13 | $44.47M derived: sum of 3 quarters · filed 2026-05-13 | $44.42M derived: sum of 4 quarters · filed 2026-05-13 | ||||
| 2024-12-31 | $10.09M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06 | $10.35M derived: sum of 2 quarters · filed 2026-03-06 | $10.30M derived: sum of 3 quarters · filed 2026-03-06 | $10.04M 10-K · filed 2026-03-06 | ||||
| 2024-09-30 | $266.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $220.00K derived: sum of 2 quarters · filed 2025-11-06 | -$41.00K 10-Q · filed 2025-11-06 | $72.71M derived: sum of 4 quarters · filed 2025-11-06 | ||||
| 2024-06-30 | -$46.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | -$307.00K 10-Q · filed 2025-08-12 | $72.45M derived: sum of 3 quarters · filed 2025-08-12 | $73.03M derived: sum of 4 quarters · filed 2025-08-12 | ||||
| 2024-03-31 | -$261.00K 10-Q · filed 2025-05-13 | $72.49M derived: sum of 2 quarters · filed 2025-05-13 | $73.08M derived: sum of 3 quarters · filed 2025-05-13 | $86.15M derived: sum of 4 quarters · filed 2025-05-13 | ||||
| 2023-12-31 | $72.75M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $73.34M derived: sum of 2 quarters · filed 2025-02-27 | $86.41M derived: sum of 3 quarters · filed 2025-02-27 | $86.11M 10-K · filed 2025-02-27 | ||||
| 2023-09-30 | $588.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $13.65M derived: sum of 2 quarters · filed 2024-11-12 | $13.35M 10-Q · filed 2024-11-12 | $13.31M derived: sum of 4 quarters · filed 2024-11-12 | ||||
| 2023-06-30 | $13.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $12.76M 10-Q · filed 2024-08-08 | $12.72M derived: sum of 3 quarters · filed 2024-08-08 | $44.78M derived: sum of 4 quarters · filed 2024-08-08 | ||||
| 2023-03-31 | -$302.00K 10-Q · filed 2024-05-09 | -$345.00K derived: sum of 2 quarters · filed 2024-05-09 | $31.71M derived: sum of 3 quarters · filed 2024-05-09 | $53.30M derived: sum of 4 quarters · filed 2024-05-09 | ||||
| 2022-12-31 | -$43.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | $32.02M derived: sum of 2 quarters · filed 2024-03-27 | $53.60M derived: sum of 3 quarters · filed 2024-03-27 | $56.78M 10-K · filed 2024-03-27 | ||||
| 2022-09-30 | $32.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $53.64M derived: sum of 2 quarters · filed 2023-11-07 | $56.82M 10-Q · filed 2023-11-07 | $69.36M derived: sum of 4 quarters · filed 2023-11-07 | ||||
| 2022-06-30 | $21.58M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $24.76M 10-Q · filed 2023-08-10 | $37.30M derived: sum of 3 quarters · filed 2023-08-10 | $37.42M derived: sum of 4 quarters · filed 2023-08-10 | ||||
| 2022-03-31 | $3.18M 10-Q · filed 2023-05-11 | $15.72M derived: sum of 2 quarters · filed 2023-05-11 | $15.84M derived: sum of 3 quarters · filed 2023-05-11 | $33.86M derived: sum of 4 quarters · filed 2023-05-11 | ||||
| 2021-12-31 | $12.54M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $12.66M derived: sum of 2 quarters · filed 2023-02-28 | $30.68M derived: sum of 3 quarters · filed 2023-02-28 | $65.10M 10-K · filed 2023-02-28 | $65.10M 10-K · filed 2022-03-15 | |||
| 2021-09-30 | $125.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $18.14M derived: sum of 2 quarters · filed 2022-11-10 | $52.56M 10-Q · filed 2022-11-10 | $52.56M 10-Q · filed 2021-11-09 | $75.27M derived: sum of 4 quarters · filed 2022-11-10 | |||
| 2021-06-30 | $18.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $52.44M 10-Q · filed 2022-08-11 | $52.44M 10-Q · filed 2021-08-10 | $75.14M derived: sum of 3 quarters · filed 2022-08-11 | $211.29M derived: sum of 4 quarters · filed 2022-08-11 | |||
| 2021-03-31 | $34.42M 10-Q · filed 2022-05-12 | $34.42M 10-Q · filed 2021-05-17 | $57.12M derived: sum of 2 quarters · filed 2022-05-12 | $193.27M derived: sum of 3 quarters · filed 2022-05-12 | $247.81M derived: sum of 4 quarters · filed 2022-05-12 | |||
| 2020-12-31 | $22.70M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $158.85M derived: sum of 2 quarters · filed 2022-03-15 | $213.39M derived: sum of 3 quarters · filed 2022-03-15 | $213.49M 10-K · filed 2022-03-15 | ||||
| 2020-09-30 | $136.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $190.69M derived: sum of 2 quarters · filed 2021-11-09 | $190.78M 10-Q · filed 2021-11-09 | $190.83M derived: sum of 4 quarters · filed 2021-11-09 | ||||
| 2020-06-30 | $54.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | $54.64M 10-Q · filed 2021-08-10 | $54.68M derived: sum of 3 quarters · filed 2021-08-10 | $54.63M derived: sum of 4 quarters · filed 2021-08-10 | ||||
| 2020-03-31 | $96.71K 10-Q · filed 2021-05-17 | $141.65K derived: sum of 2 quarters · filed 2021-05-17 | $85.86K derived: sum of 3 quarters · filed 2021-05-17 | -$70.29K derived: sum of 4 quarters · filed 2021-05-17 | ||||
| 2019-12-31 | $44.94K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | -$10.86K derived: sum of 2 quarters · filed 2021-02-25 | -$167.00K derived: sum of 3 quarters · filed 2021-02-25 | $12.53M 10-K · filed 2021-02-25 | ||||
| 2019-09-30 | -$55.80K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | -$211.94K derived: sum of 2 quarters · filed 2020-11-09 | $12.49M 10-Q · filed 2020-11-09 | $44.01M derived: sum of 4 quarters · filed 2020-11-09 | ||||
| 2019-06-30 | -$156.15K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-11 | $12.54M 10-Q · filed 2020-08-11 | $44.06M derived: sum of 3 quarters · filed 2020-08-11 | $48.47M derived: sum of 4 quarters · filed 2020-08-11 | ||||
| 2019-03-31 | $12.70M 10-Q · filed 2020-05-13 | $44.22M derived: sum of 2 quarters · filed 2020-05-13 | $48.63M derived: sum of 3 quarters · filed 2020-05-13 | $45.17M derived: sum of 4 quarters · filed 2020-05-13 | ||||
| 2018-12-31 | $31.52M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | $35.93M derived: sum of 2 quarters · filed 2020-03-27 | $32.47M derived: sum of 3 quarters · filed 2020-03-27 | $32.49M 10-K · filed 2020-03-27 | ||||
| 2018-09-30 | $4.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | $952.94K derived: sum of 2 quarters · filed 2019-11-13 | $971.43K 10-Q · filed 2019-11-13 | $971.43K derived: sum of 4 quarters · filed 2019-11-13 | ||||
| 2018-06-30 | -$3.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-13 | -$3.44M 10-Q · filed 2019-08-13 | -$3.44M derived: sum of 3 quarters · filed 2019-08-13 | $9.55M derived: sum of 4 quarters · filed 2019-08-13 | ||||
| 2018-03-31 | $18.49K 10-Q · filed 2019-05-14 | $18.49K derived: sum of 2 quarters · filed 2019-05-14 | $13.01M derived: sum of 3 quarters · filed 2019-05-14 | |||||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | $12.99M derived: sum of 2 quarters · filed 2019-04-01 | $15.84M 10-K · filed 2019-04-01 | |||||
| 2017-09-30 | $12.99M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | $15.84M 10-Q · filed 2018-11-13 | ||||||
| 2017-06-30 | $2.85M 10-Q · filed 2018-08-14 | |||||||
| 2015-06-30 | $42.21K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05 | -$123.45K 10-Q · filed 2015-08-05 | ||||||
| 2015-03-31 | -$165.67K 10-Q · filed 2015-05-07 | |||||||
| 2014-09-30 | $10.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | $12.81M derived: sum of 2 quarters · filed 2015-08-05 | $14.18M 10-Q · filed 2014-11-06 | |||||
| 2014-06-30 | $2.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05 | $3.68M 10-Q · filed 2015-08-05 | ||||||
| 2014-03-31 | $1.38M 10-Q · filed 2015-05-07 | |||||||
| 2013-09-30 | $840.35K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | $4.30M derived: sum of 2 quarters · filed 2014-11-06 | $4.24M 10-Q · filed 2014-11-06 | $4.36M derived: sum of 4 quarters · filed 2014-11-06 | ||||
| 2013-06-30 | $3.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-05 | $3.40M 10-Q · filed 2014-08-05 | $3.52M derived: sum of 3 quarters · filed 2014-08-05 | $4.73M derived: sum of 4 quarters · filed 2014-08-05 | ||||
| 2013-03-31 | -$60.36K 10-Q · filed 2014-05-08 | $61.78K derived: sum of 2 quarters · filed 2014-05-08 | $1.27M derived: sum of 3 quarters · filed 2014-05-08 | $455.10K derived: sum of 4 quarters · filed 2014-05-08 | ||||
| 2012-12-31 | $122.14K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-14 | $1.33M derived: sum of 2 quarters · filed 2013-11-07 | $515.46K derived: sum of 3 quarters · filed 2013-11-07 | $3.72M 10-K · filed 2013-03-14 | ||||
| 2012-09-30 | $1.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | $393.32K derived: sum of 2 quarters · filed 2013-11-07 | $3.60M 10-Q · filed 2013-11-07 | $3.63M derived: sum of 4 quarters · filed 2013-11-07 | ||||
| 2012-06-30 | -$815.05K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | $2.39M 10-Q · filed 2013-08-08 | $2.42M derived: sum of 3 quarters · filed 2013-08-08 | $2.37M derived: sum of 4 quarters · filed 2013-08-08 | ||||
| 2012-03-31 | $3.20M 10-Q · filed 2013-05-08 | $3.24M derived: sum of 2 quarters · filed 2013-05-08 | $3.19M derived: sum of 3 quarters · filed 2013-05-08 | $8.97M derived: sum of 4 quarters · filed 2013-05-08 | ||||
| 2011-12-31 | $31.05K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-14 | -$16.87K derived: sum of 2 quarters · filed 2013-03-14 | $5.77M derived: sum of 3 quarters · filed 2013-03-14 | $5.78M 10-K · filed 2013-03-14 | ||||
| 2011-09-30 | -$47.92K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06 | $5.74M derived: sum of 2 quarters · filed 2012-11-06 | $5.75M 10-Q · filed 2012-11-06 | $21.63M derived: sum of 4 quarters · filed 2013-03-14 | ||||
| 2011-06-30 | $5.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07 | $5.80M 10-Q · filed 2012-08-07 | $21.68M derived: sum of 3 quarters · filed 2013-03-14 | $25.15M derived: sum of 4 quarters · filed 2013-03-14 | ||||
| 2011-03-31 | $12.76K 10-Q · filed 2012-05-10 | $15.89M derived: sum of 2 quarters · filed 2013-03-14 | $19.36M derived: sum of 3 quarters · filed 2013-03-14 | |||||
| 2010-12-31 | $15.88M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-14 | $19.35M derived: sum of 2 quarters · filed 2013-03-14 | $21.46M 10-K · filed 2013-03-14 | |||||
| 2010-09-30 | $3.47M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-09 | $5.58M 10-Q · filed 2011-11-09 | ||||||
| 2010-06-30 | $2.11M 10-Q · filed 2011-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B |